Breast cancer is the second most common primary tumor responsible for brain metastasis (2, 3), especially from women with HER2+ and triple negative [TN, estrogen receptor negative (ER−), progesterone receptor negative (PR−), and HER2−] tumors (4–6). Here, ERBB2 is linked to neoplasm.